Topical Dutasteride on Male pattern hairloss.

Efficacy and safety of topical dutasteride solution in Androgenetic alopecia.

Status

Not yet recruiting

Phases

Phase 3

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12626000082303

Enrollment

Registered

2026-01-22

Start date

2026-01-26

Completion date

2026-02-23

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

There is some evidence Topical application of dutasteride solution is effective in treating androgenetic alopecia. Local pilot study aims to study the efficacy of topical dutasteride solution to validate this claim.

Interventions

Topical 0.025% Dutasteride solution application every 2 weeks. Total of 3ml of solution will be applied over the entire area of hairloss, including the frontal hairline, and vertex. The total duration of the intervention is 24 weeks. The application each time will be carried out in the clinic. There are no additional strategies to monitor adherence since it will be applied in the clinic.

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

Male

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

Norwood-Hamilton grade 3-5 Androgenetic alopecia.

Exclusion criteria

Female Spouses of pregnant patient Other types of alopecia Other medical treatment for hairloss within last 6 months

Outcome results